Brind.
  1. Tempus AI is part of the Tempus group, and Sophia Genetics partners with AstraZeneca while Tempus collaborates with Boehringer Ingelheim on cancer therapies.

AstraZeneca and SOPHiA GENETICS announced a collaboration to develop companion diagnostics.

2 reports, 1 independent Updated Aug 4
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

AstraZeneca and SOPHiA GENETICS announced a collaboration to develop companion diagnostics.

Who's involved

What this event is mainly about
AstraZeneca

Keep exploring

Part of

Tempus AI is part of the Tempus group, and Sophia Genetics partners with AstraZeneca while Tempus collaborates with Boehringer Ingelheim on cancer therapies. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped
1 more outlet ran the same wire story